Avalo Therapeutics Inc.

NASDAQ: AVTX · Real-Time Price · USD
4.12
-0.21 (-4.85%)
At close: Jun 06, 2025, 3:59 PM
4.19
1.70%
After-hours: Jun 06, 2025, 05:40 PM EDT

Avalo Therapeutics Statistics

Share Statistics

Avalo Therapeutics has 10.83M shares outstanding. The number of shares has increased by 931.97% in one year.

10.83M
931.97%
1.99%
61.5%
n/a
73
0.09%

Short Selling Information

The latest short interest is 86.49K, so 0.8% of the outstanding shares have been sold short.

86.49K
0.8%
0.81%
1.61

Valuation Ratios

The PE ratio is -1.72 and the forward PE ratio is -0.87. Avalo Therapeutics's PEG ratio is 0.02.

-1.72
-0.87
136.95
3.1
0.45
-1.23
0.02
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for Avalo Therapeutics.

n/a
n/a
n/a
n/a

Financial Position

The company has a current ratio of 19.96, with a Debt / Equity ratio of 0.

19.96
19.96
0
-0.01
-0.01
-20.65

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

n/a
n/a
n/a
$19,173.91
$-1,527,347.83
23
0
n/a

Taxes

114K
-0.33%

Stock Price Statistics

The stock price has increased by -61.15% in the last 52 weeks. The beta is 0.71, so Avalo Therapeutics's price volatility has been higher than the market average.

0.71
-61.15%
4.95
8.1
50.07
78,811

Income Statement

In the last 12 months, Avalo Therapeutics had revenue of 441K and earned -35.13M in profits. Earnings per share was -4.32.

441K
-26.83M
-68.51M
-35.13M
-68.51M
-31.7M
-4.32
Full Income Statement

Balance Sheet

The company has 134.55M in cash and 568K in debt, giving a net cash position of 133.98M.

134.55M
568K
133.98M
-370.26M
138.52M
121.33M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -49.06M and capital expenditures 0, giving a free cash flow of -49.06M.

-49.06M
n/a
-49.06M
-6.04
Full Cash Flow Statement

Margins

Gross margin is -6084.81%, with operating and profit margins of -15535.6% and -7965.76%.

-6084.81%
-15535.6%
-7939.91%
-7965.76%
-15535.6%
-15535.6%
-11123.81%

Dividends & Yields

AVTX does not appear to pay any dividends at this time.

n/a
n/a
n/a
n/a
n/a
n/a
Dividend Details

Analyst Forecast

The average price target for AVTX is $30, which is 602.6% higher than the current price. The consensus rating is "Buy".

$30
602.6%
Buy
6
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

n/a
n/a
n/a
n/a

Stock Splits

The last stock split was on Dec 29, 2023. It was a backward split with a ratio of 1:240.

Dec 29, 2023
backward
1:240

Scores

-2.49
3